Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Escitalopram and Sleep Architecture in MDD
NCT00442481Phase 4Unknown
- Sponsor
- Sheba Medical Center
- Start
- Feb 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of escitalopram in major depressive disorder (MDD), sponsored by Sheba Medical Center. Primary endpoint: Latency of the first REM episode of the night. Status: unknown.
02
Drugs
escitalopram
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT00442481.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00442481.